分子靶向药物治疗宫颈癌研究进展  

Advances in molecular targeted drugs in the treatment of cervical cancer

作　　者：程璐[1] 李林[1] 谢旭[1] 

机构地区：[1]广西中医药大学附属瑞康医院妇科,南宁530011

出　　处：《实用药物与临床》2015年第5期599-603,共5页Practical Pharmacy and Clinical Remedies

摘　　要：宫颈癌是女性生殖系统发病率第二的恶性肿瘤。主要的治疗方法为手术、放疗或化疗。近年来,分子靶向药物的蓬勃发展为晚期恶性肿瘤的治疗提供了一个新途径,在宫颈癌的治疗上也取得了一定的成绩,本文就靶向药物治疗宫颈癌的研究进展作一简要综述。Cervical cancer is on the second degree in the incidence of malignancies for female reproductive system, the main treatment includes surgery, radiotherapy or chemotherapy. In recent years, the rapid development of molecular targeted drugs provides a new way for the treatment of advanced cancer, and some achievements in the treat- ment of cervical cancer has also been obtained. A brief summary about the progress on cervical cancer targeted drug therapy has been summarized in this paper.

关 键 词：分子靶向药物 宫颈癌 研究进展 

分 类 号：R737.33[医药卫生—肿瘤]